Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Hitomi Akazawa"'
Autor:
Naoki Amada, Hitomi Akazawa, Yuta Ohgi, Kenji Maeda, Haruhiko Sugino, Nobuyuki Kurahashi, Tetsuro Kikuchi, Takashi Futamura
Publikováno v:
Neuropsychopharmacology Reports, Vol 39, Iss 4, Pp 279-288 (2019)
Abstract Background Long‐term antipsychotic treatment in patients with schizophrenia can induce supersensitivity psychosis and tardive dyskinesia which is thought to be caused by dopamine D2 receptor sensitization. We evaluated the effects of brexp
Externí odkaz:
https://doaj.org/article/66b91c71c5e2434aa05a0dc090222e04
Autor:
Nobuyuki Kurahashi, Naoki Amada, Hitomi Akazawa, Tetsuro Kikuchi, Haruhiko Sugino, Takashi Futamura, Yuta Ohgi, Kenji Maeda
Publikováno v:
Neuropsychopharmacology Reports. 39:279-288
Background Long-term antipsychotic treatment in patients with schizophrenia can induce supersensitivity psychosis and tardive dyskinesia which is thought to be caused by dopamine D2 receptor sensitization. We evaluated the effects of brexpiprazole on
Autor:
Hiroyuki Sasabe, Yosuke Kaneko, Masayuki Furukawa, Masayuki Matsunaga, Eiji Kashiyama, Yukihiro Hirao, Mitsuhiko Kawabata, Noriyuki Koyama, Toshihisa Koga, Hitomi Akazawa, Kenji Takeuchi
Publikováno v:
Xenobiotica; the fate of foreign compounds in biological systems. 51(5)
The pharmacokinetics of brexpiprazole were investigated in the in vitro and in vivo.The total body clearance of brexpiprazole in rat and monkey was 2.32 and 0.326 L/h/kg, respectively, after intrav...
Autor:
Nobuaki Ito, Robert D. McQuade, Christoffer Bundgaard, Hiroshi Yamashita, Hitomi Akazawa, Arne Mørk, Takashi Futamura, Alan L. Pehrson, Kenji Maeda, Tetsuro Kikuchi, Tine B. Stensbøl, Jørn Arnt, Naoki Amada, Haruhiko Sugino, Morten Hentzer, Jun Shimada, Vibeke Nielsen
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 350:589-604
Brexpiprazole (OPC-34712, 7-{4-[4-(1-benzothiophen-4-yl)piperazin-1-yl]butoxy}quinolin-2(1H)-one) is a novel drug candidate in clinical development for psychiatric disorders with high affinity for serotonin, dopamine, and noradrenaline receptors. In
Autor:
Tine B. Stensbøl, Christoffer Bundgaard, Naoki Amada, Haruhiko Sugino, Jørn Arnt, Kenji Maeda, Tetsuro Kikuchi, Hitomi Akazawa, Robert D. McQuade, Linda Lerdrup
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 350(3)
Brexpiprazole (OPC-34712, 7-{4-[4-(1-benzothiophen-4-yl)piperazin-1-yl]butoxy}quinolin-2(1H)-one) is a novel serotonin-dopamine activity modulator with partial agonist activity at serotonin 1A (5-HT1A) and D2/3 receptors, combined with potent antagon
Autor:
Hitomi Akazawa
Publikováno v:
Zeitschrift der Japanischen Mikrobiologische Gesellschaft. 37:150-160
Autor:
Masuo Kudo, Hitomi Akazawa
Publikováno v:
Zeitschrift der Japanischen Mikrobiologische Gesellschaft. 35:1081-1094
Autor:
Itsuo Hamada, Hitomi Akazawa
Publikováno v:
Zeitschrift der Japanischen Mikrobiologische Gesellschaft. 32:461-468
Autor:
Itsuo Hamada, Hitomi Akazawa
Publikováno v:
Zeitschrift der Japanischen Mikrobiologische Gesellschaft. 32:1260-1268
Publikováno v:
Zeitschrift der Japanischen Mikrobiologische Gesellschaft. 34:422-431